Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7 years follow up study. Issue 1 (3rd January 2017)

• Record Type: Journal Article
• Authors: Jiménez-Garcia, Rodrigo; Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Gómez-Campelo, Paloma; San Andrés-Rebollo, Francisco J.; de Burgos-Lunar, Carmen; Cárdenas-Valladolid, Juan; Abánades-Herranz, Juan Carlos; Salinero-Fort, Miguel Angel
• Is Part Of: Vaccine. Volume 35:Issue 1(2017)
• Page Start: 101
• Page End: 108
• Publication Date: 2017-01-03
• Subjects: Influenza -- Vaccine -- Uptake -- Diabetes -- Perceptions -- Predictors; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2016.11.039
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Of 2288 T2 DM patient 65.7% had received the influenza vaccine in 2013. Of 2288 T2 DM patient 19.23% had not received any influenza vaccine from 2007 to 2013. Vaccination uptake increased with GP visits, number of previous influenza vaccines and duration of T2 DM. Higher mean glycated haemoglobin was associated with a reduced probability of vaccination. The most common reasons for refusal were the perception of not being at risk and fear of adverse reactions. Abstract: Objectives: We aim to determine influenza vaccination uptake among people with diabetes included in the MADIABETES cohort study in order to identify predictors of uptake and to analyze reasons for adherence and non-adherence with vaccination. Methods: Using data from the MADIABETES Study we conducted a retrospective case record form based study without controls. We included outpatients with type 2 diabetes mellitus. Information was obtained from computerized clinical records and by telephone survey. The main dependent variables were influenza vaccination uptake in the year 2013 and the reason for receiving or refusing vaccination. Results: Overall, 65.7% had received the influenza vaccine in 2013. The mean number of influenza vaccines received from 2007 to 2013 was 3.24 (SD1.15), although 19.23% had not received any influenza vaccine and 23.3% had been vaccinated against pneumococcus. The variables that increased the probability of being vaccinated were inclusion in the age-based recommendation (⩾60 years), having a chronic respiratory disease, previous pneumococcal vaccination, higher number of visits to the general practitioner, higher number of influenza vaccines, and longer time since diabetes diagnosis. A higher mean glycated haemoglobin value in 2013 was associated with a reduced probability of vaccination. Most patients (90%) agreed to be vaccinated following their physician's advice because of their age or their chronic conditions. The most common reason for refusal among men was the belief that they were not at risk (41.6% vs. 29.79% in women); the most common reason for refusal among women was fear of adverse reactions (32.53% vs. 20.23% in men). Conclusions: The uptake of influenza vaccination among diabetic patients in the present study was below desirable levels. The main barrier to vaccination was lack of knowledge regarding the need for and risks and advantages of influenza vaccination. Healthcare professionals should educate and encourage influenza vaccination among people with diabetes.